Pharmacovigilance Blog

ICSR Management

Decoding Why Severe Isn’t Always Serious

This article demystifies the distinction between the two, the terms why severe isn’t always serious are often misunderstood—and mistakenly used interchangeably.

Bala

Read

Exploring Adverse Events

Beyond ADRs: Reports Managed in PV

This blog covers the following: Introduction Pharmacovigilance involves much more than just managing adverse reactions or events with…

Bala

Read

Who & When & How

Pharmacists and Pharmacovigilance

This blog features: Introduction This article highlights the vital role of pharmacists in pharmacovigilance, emphasizing why they are…

Bala

Read

ICSR Management

Marketing Authorization Holder (MAH)

This comprehensive blog that guide o explore the critical role and responsibilities of Marketing Authorization Holder (MAH) in the pharmaceutical industry.

Bala

Read

Exploring Adverse Events

Death: An Adverse Event

This blog features: Introduction This comprehensive article explores how to handle fatal cases, which are classified under the…

Bala

Read

Public Authorities and Safety

Pharmacovigilance Regulatory Timelines: A Complete Guide

This blog covers: Introduction In today’s regulatory environment, every product must adhere to specific timelines to ensure safety,…

Bala

Read

ICSR Management

Risk Register: An Overview

This blog covers the following topics: Overview Risk registers are a critical component of any business, helping to…

Bala

Read

Drug safety and pharmacovigilance

📑 Investigational Brochure (IB): An Overview

Welcome to our informative article, where we unravel the concept of the Investigational Brochure (IB). In this comprehensive piece, we aim to provide a clear understanding of what an IB is, its purpose, significance, and the important components it comprises.

Bala

Read